Our work gets us noticed. UBMD physicians make headlines for raising the bar on clinical care, leading community health initatives and conducting groundbreaking research, among other advancements and accomplishments.
UB Neurosurgery (UBNS) has been selected to participate in the University of Miami Miller School of Medicine’s 2024 Student Summer Research Scholarship in Neurosurgery program.
The Argentieri family of Hornell, New York, is living proof of the wondrous scientific and medical advances that have been made in the treatment of cystic fibrosis (CF).
A UB researcher who is a leading expert on retinopathy of prematurity (ROP) has published a study that could change the standard of care for the condition.
Amit Kandel, MD, MBA, associate professor of neurology, has been honored by the American Academy of Neurology (AAN) with its 2024 Clerkship Director Innovation Award.
One of the most dramatic success stories in modern medicine is the treatment of cystic fibrosis (CF), where therapeutic breakthroughs have dramatically reduced patients’ symptoms and increased their life expectancies.
Both the adult and pediatric Kaleida Health epilepsy centers have achieved accreditation as Level 4 NAEC (National Association of Epilepsy Centers) centers.
Gabriela K. Popescu, PhD, and Thomas A. Russo, MD, have been elected Fellows of the American Association for the Advancement of Science (AAAS), which is the world’s largest general scientific society and publisher of the journal Science.